The role of mechanical devices in treating female sexual dysfunction and enhancing the female sexual response

被引:29
作者
Billups, KL
机构
[1] EpiCtr Sexual Hlth & Med, Edina, MN 55435 USA
[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
关键词
female sexual dysfunction; clitoral engorgement; arousal and orgasm disorder;
D O I
10.1007/s00345-002-0269-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Female sexual dysfunction (FSD) is a common medical problem estimated to affect about 40 million American women. In 1998, the American Foundation of Urologic Disease (AFUD) Consensus Panel classified FSD into four different categories: sexual desire disorder, sexual arousal disorder, orgasmic disorder, and sexual pain disorder. This article will focus on the role of mechanical devices to treat sexual arousal and orgasm disorders and to enhance the female sexual response. Mechanical devices may work through vibratory stimulation or by causing clitoral vascular engorgement using a vacuum system. While a number of vibratory stimulating devices are available, only one U.S. Food and Drug Administration cleared-to-market device is available by prescription to treat FSD, the Eros Therapy device (UroMetrics, Inc., St. Paul, Minn., USA). The Eros Therapy is a small, battery-powered device used to gently apply direct vacuum over the clitoris causing the clitoral erectile chambers and labia to fill with blood. This article will review the rationale and benefits of using mechanical devices to treat FSD.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 17 条
  • [1] Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications
    Basson, R
    Berman, J
    Burnett, A
    Derogatis, L
    Ferguson, D
    Fourcroy, J
    Goldstein, I
    Graziottin, A
    Heiman, J
    Laan, E
    Leiblum, S
    Padma-Nathan, H
    Rosen, R
    Segraves, K
    Segraves, RT
    Shabsigh, R
    Sipski, M
    Wagner, G
    Whipple, B
    [J]. JOURNAL OF UROLOGY, 2000, 163 (03) : 888 - 893
  • [2] Female sexual dysfunction: Incidence, pathophysiology, evaluation, and treatment options
    Berman, JR
    Berman, L
    Goldstein, I
    [J]. UROLOGY, 1999, 54 (03) : 385 - 391
  • [3] The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction
    Berman, LA
    Berman, JR
    Werbin, T
    Chabra, S
    Goldstein, I
    [J]. JOURNAL OF SEX & MARITAL THERAPY, 2001, 27 (05) : 427 - 433
  • [4] A new non-pharmacological vacuum therapy for female sexual dysfunction
    Billups, KL
    Berman, L
    Berman, J
    Metz, ME
    Glennon, ME
    Goldstein, I
    [J]. JOURNAL OF SEX & MARITAL THERAPY, 2001, 27 (05) : 435 - 441
  • [5] BILLUPS KL, 2002, ANN M AM UR ASS ORL
  • [6] The therapeutic use of androgens in women
    Davis, SR
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1999, 69 (1-6) : 177 - 184
  • [7] Diederichs W., 1991, INT J IMPOT RES, V3, P7
  • [8] FLAHERTY E, 2001, FEM SEX FUNCT FOR BO
  • [9] HURLBERT DF, 1995, J SEX MARITAL THER, V21, P21
  • [10] Sexual dysfunction in the United States - Prevalence and predictors
    Laumann, EO
    Paik, A
    Rosen, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (06): : 537 - 544